The market seems unfazed by the EPS figure, possibly due to prior pricing in. The company's poor performance over the past year concludes a disappointing five-year run, with shareholders facing annual losses of 1.6%. This long-term share price decline could be a warning sign, though contrarian investors might see a potential turnaround.

With falling returns and sales despite more business investment, the future doesn't look bright for long-term performance without positive change. Luxi Chemical Group's high liabilities to asset ratio of 42% could add risk for investors.